Company Filing History:
Years Active: 2017-2019
Title: Kyoung Suk Kim: Innovator in Dual-Fuel Engine Technology and Anticancer Drug Development
Introduction
Kyoung Suk Kim, an accomplished inventor based in Incheon, South Korea, has made significant contributions to the fields of engine control systems and cancer treatment technologies. With two patents to his name, he showcases innovative thinking that combines advanced engineering with medical applications.
Latest Patents
Kyoung Suk Kim's first notable patent is for a **Control System of Dual-Fuel Engine**. This sophisticated system includes a sensing unit that generates information by monitoring parameters related to the dual-fuel engine. The main control unit analyzes the engine's state based on this information to produce a control signal, managing the micro-pilot injection and gas fuel inlet valves. Additionally, a deep learning unit enhances the system by analyzing the engine state and providing valuable insights to optimize performance.
His second patent involves an **Antibody-Linker-Drug Conjugate**, which features a conjugation of an antibody with a cytotoxic drug via an enzyme cleavable peptide linker. This innovation facilitates a targeted approach to cancer therapy, potentially improving the efficacy of treatments by delivering drugs directly to cancer cells.
Career Highlights
Throughout his career, Kyoung Suk Kim has operated within reputable companies such as Samwoo Immersion Co., Ltd. and Celltrion Inc. These roles have provided him with the necessary environment to foster his innovative spirit and contribute to groundbreaking technologies.
Collaborations
Kyoung Suk Kim has shared his professional journey with notable coworkers, including Young Jun Park and Jin-kyo Jeong. Their collaborative efforts likely contributed to the success of his innovative projects and patents.
Conclusion
Kyoung Suk Kim stands out as a visionary inventor whose work transcends traditional boundaries, impacting both the automotive and pharmaceutical industries. His dual-fuel engine control system represents a significant advancement in efficient energy use, while his antibody-linker-drug conjugate underscores his commitment to addressing critical health challenges. As he continues to innovate, Kyoung Suk Kim will undoubtedly leave a lasting mark on the fields he engages with.